U.S. Imposes 100% Tariff on Brand Name Medicines Starting Today
WHAT HAPPENED
The United States has begun imposing a 100% tariff on brand name medications imported by large pharmaceutical companies. Companies with pricing and local manufacturing agreements pay 0%; generics are exempt.
WHY IT MATTERS
For a company without an agreement, importing a medicine costs double. The pharmacy price does not necessarily increase today, but it could over time. Patients, insurers, and health systems would feel it first; European factories would also be affected.
AND FOR YOUR PORTFOLIO
The change divides pharmaceutical companies between those that produce more in the United States and those that rely on imports. The former avoid the tariff, while the latter face pressure on costs and prices. Generic manufacturers are excluded from this measure.
💬 TELL IT LIKE THIS
“The tariff does not automatically increase the price of all medicines: it rewards manufacturing in the United States and excludes generics.”